Bookbuilding IPO | ₹[.] Cr | Listing at NSE SME |
Q-Line Biotech Ltd. IPO is a Book Build Issue consisting solely of fresh issue of upto 0.71 crore equity shares.
The equity shares are proposed to be listed on the NSE SME. Hem Securities Ltd. is the book running lead manager and Purva Sharegistry (India) Pvt.Ltd. is the registrar of the issue. Key details like IPO dates, IPO price bands and lot size are yet to be announced.
Refer to Q-Line Biotec IPO DRHP for more details.
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | |
| Lot Size | |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 70,53,200 shares (agg. up to ₹[.] Cr) |
| Fresh Issue | 70,53,200 shares (agg. up to ₹[.] Cr) |
| Share Holding Pre Issue | 1,62,74,999 shares |
| Description | Date |
|---|---|
| Filed with SEBI/Exchange | Tue, Sep 30, 2025 |
| SEBI/Exchange approval received | Fri, Jan 23, 2026 |
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII Shares Offered | Not less than 15% of the Net Issue |
Incorporated in 2010, Q-Line Biotech Ltd. is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.
The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through our distributor/s majorly to diagnostic service providers, hospitals and medical colleges.
The company's key manufacturing segments include indigenous manufacturing of reagents including Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics and Others (POC Devices & Rapids) and supplying/ manufacturing of in-vitro diagnostics (IVD), Pathology equipment’s & devices.
As of March 31, 2025, the company had 313 permanent employees.
Competitive Strengths:
Q-Line Biotech Ltd.'s revenue increased by 56% and profit after tax (PAT) dropped by 18% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 455.49 | 339.25 | 251.58 |
| Total Income | 322.58 | 206.45 | 184.81 |
| Profit After Tax | 28.13 | 34.44 | 32.10 |
| EBITDA | 71.32 | 37.63 | 32.98 |
| NET Worth | 189.95 | 161.81 | 127.37 |
| Reserves and Surplus | 188.37 | 160.24 | 125.79 |
| Total Borrowing | 164.95 | 96.91 | 73.65 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To meet Working Capital requirements | 110.00 |
| 2 | Repayment of certain borrowing availed by the Company, in part or full | 90.00 |
| 3 | General Corporate Purpose |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 17.66% |
| ROCE | 23.74% |
| Debt/Equity | 0.87 |
| RoNW | 23.74% |
| PAT Margin | 8.97% |
| EBITDA Margin | 22.73% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 96.77% |
Purva Sharegistry (India) Pvt.Ltd.
Lead Manager Reports
Q-Line Biotec IPO is a SME IPO of 70,53,200 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at To be declared. The minimum order quantity is .
The Q-Line Biotec IPO open and close dates are not available as of now.
Purva Sharegistry (India) Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Q-Line Biotec IPO using UPI as a payment gateway. Zerodha customers can apply in Q-Line Biotec IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Q-Line Biotec IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Q-Line Biotec IPO dates are not announced. Please check back again after some time.
Q-Line Biotec IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Q-Line Biotec IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Q-Line Biotec IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Q-Line Biotec IPO allotment status.
The Q-Line Biotec IPO listing date is not yet announced. The tentative date of listing is .
